医学
血管炎
环磷酰胺
加药
重症监护医学
ANCA相关性血管炎
血浆置换术
维持疗法
疾病
免疫学
内科学
化疗
抗体
作者
Adam Morris,Duvuru Geetha
标识
DOI:10.1016/j.berh.2023.101828
摘要
Since its first description 40 years ago, huge strides have been made in the management of ANCA-associated vasculitis with improved patient outcomes. The use of cyclophosphamide and/or B-cell depleting therapy alongside glucocorticoids remains the cornerstone of therapy in organ or life-threatening disease, but recent trials have re-evaluated existing treatment strategies, alongside the development of new treatment targets. This has led to refinement of the role of plasma exchange, the use of reduced dosing of oral glucocorticoids with improved patient outcomes, as well as other treatment adjuvants/options of steroid minimization including C5a receptor antagonism and IL-5 inhibition. In this review we examine developments in remission induction therapy for ANCA-associated vasculitis.
科研通智能强力驱动
Strongly Powered by AbleSci AI